Abstract
Several lines of evidence suggest that nitric oxide (NO), generated through nitric oxide synthase (NOS) by cleavage of terminal guanidino nitrogen from L-arginine, mediates tumor cell killing by mononuclear phagocytes. Natural killer (NK) cells are cytotoxic effector cells that lyse a variety of tumor and virus-infected cells in a MHC-unrestricted manner. NK cells cultured with interleukin 2 proliferate and acquire the ability to lyse a wide range of targets, including NK-resistant tumor cells (LAK activity). The present study was designed to investigate whether a NOS pathway exists in fresh or IL-2-activated NK cells and to assess the importance of NO synthesis in their activation and cytotoxic functions. NKR-P1 triggering, which is known to induce NK cell activation and mediate reverse ADCC, was able to induce arginine metabolism with consequent increase of nitrite and citrulline levels. Moreover, stimulated NO synthesis leads to guanylate cyclase activity with consequent cGMP generation. We also report that cytotoxic activities of fresh or IL-2-activated NK cells appear to be dependent on arginine levels in medium. Tumoricidal activity of both these effector cells, assessed against YAC-1 and P815 target cells, respectively, ...Continue Reading
Citations
Nov 21, 1998·European Journal of Clinical Investigation·M OgawaY Matsuzawa
Aug 10, 2000·Scandinavian Journal of Immunology·M D Jyothi, A Khar
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·I VouldoukisM D Mossalayi
Nov 1, 1995·Scandinavian Journal of Immunology·L XiaoG A Qureshi
Jul 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Marcella FerlitoCharles J Lowenstein
Jul 17, 1995·Biochemical Pharmacology·L XiaoP H Eneroth
May 19, 2009·The Journal of Nutritional Biochemistry·Chiu-Li YehSung-Ling Yeh
Aug 5, 1998·International Journal of Clinical & Laboratory Research·P MartellettiM Giacovazzo
Apr 10, 1997·International Journal of Cancer. Journal International Du Cancer·T YamashitaF Sendo
Nov 24, 1998·Infection and Immunity·M G SchwachaT K Eisenstein
Dec 1, 1995·Immunology Today·B DugasJ P Kolb
Dec 19, 2000·Free Radical Biology & Medicine·M HerdenerG Bauer
Nov 5, 1997·Journal of Pain and Symptom Management·M Anbar, B M Gratt
Mar 1, 1997·Research in Immunology·G Palmieri, A Santoni
Nov 1, 1995·Research in Immunology·F Ouaaz
Nov 1, 1995·Research in Immunology·R TestiA Santoni
Jun 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·G Bauer
May 27, 2021·Cellular and Molecular Life Sciences : CMLS·Adrià-Arnau Martí I Líndez, Walter Reith
Feb 14, 1998·Immunity·A DiefenbachC Bogdan
Jan 1, 1995·Advances in Neuroimmunology·M G CifoneA Santoni
Nov 1, 1996·Journal of Virology·M S RolphI A Ramshaw